Scintigraphy Study in Healthy Volunteers to Characterize the Performance of ALLN-346 Tablets
Clinical trial NCT05168683 · COMPLETED
Trial details
- NCT number
- NCT05168683
- Sponsor
- Allena Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-11
- Primary completion
- 2022-02-23
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.